Product Information
TOBRAMYCIN-DEXAMETH OPHTH SUSP is a generic product labeled by Padagis US LLC, priced at $4.2681 per ML under NDC 00574403105. Its NADAC has been published 221 times since Jun 1, 2022.
FDA first approved this application on Feb 11, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
1; 3 mg/mL; mg/mL
Manufacturer
Padagis US LLCNDC
00574403105
Classification
Generic
Dosage Form
SUSPENSION/ DROPS
Route
OPHTHALMIC
Effective Date
8/19/2026
Active Ingredients
DEXAMETHASONE; TOBRAMYCINApproval Type
Generic (ANDA)
FDA Application
ANDA212715FDA Approved
2/11/2022
TE Code
AB
On Market Since
3/17/2022
Pharmacological Classes
Price Statistics
The NADAC for TOBRAMYCIN-DEXAMETH OPHTH SUSP has been published 221 times since Jun 1, 2022, and over the history we have for it it has declined 68.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.2681 per ML |
|---|---|
| All-time high | $14.4896 (Jul 13, 2022) |
| All-time low | $3.7216 (Jul 17, 2024) |
| 52-week high | $4.7783 |
| 52-week low | $4.1809 |
| Median price | $4.5643 |
| Average price | $5.5562 |
| Largest weekly change | +49.3% (Nov 22, 2023) |
| Weeks tracked | 221 |
| Tracking since | Jun 1, 2022 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TOBRAMYCIN-DEXAMETH OPHTH SUSP?
The current National Average Drug Acquisition Cost (NADAC) for TOBRAMYCIN-DEXAMETH OPHTH SUSP, manufactured by Padagis US LLC, is $4.2681 per ML (NDC 00574403105), effective Aug 19, 2026.
How has the price of TOBRAMYCIN-DEXAMETH OPHTH SUSP changed over time?
Over the history we have for it, the NADAC for TOBRAMYCIN-DEXAMETH OPHTH SUSP has declined 68.7%. It has been tracked across 221 weekly CMS publications since Jun 1, 2022.
What are the highest and lowest recorded NADAC prices for TOBRAMYCIN-DEXAMETH OPHTH SUSP?
Since Jun 1, 2022, the NADAC for TOBRAMYCIN-DEXAMETH OPHTH SUSP has ranged from a low of $3.7216 (Jul 17, 2024) to a high of $14.4896 (Jul 13, 2022), with a median of $4.5643 per ML.
Are there cheaper alternatives to TOBRAMYCIN-DEXAMETH OPHTH SUSP?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as TOBRAMYCIN-DEXAMETH OPHTH SUSP in a comparable dosage form, but none are currently priced below it.
Who manufactures TOBRAMYCIN-DEXAMETH OPHTH SUSP?
TOBRAMYCIN-DEXAMETH OPHTH SUSP (NDC 00574403105) is labeled by Padagis US LLC, and CMS classifies it as a generic product.